Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial proteins and membrane macromolecules serve as the primary targets for broad-spectrum antimicrobial agents, including antiseptics, disinfectants, and certain topical antibiotics. These targets include a diverse array of essential components such as cytoplasmic enzymes, structural proteins, and the phospholipid bilayers that maintain cellular integrity (CDC, 2008). Agents like alcohols (ethanol and isopropanol) work by rapidly denaturing proteins and disrupting lipid membranes, leading to cell lysis and death (StatPearls, 2023). Other agents, such as povidone-iodine, act by oxidizing key microbial functional groups and substituting microbial hydrogen with free iodine, which interferes with protein synthesis and cell membrane stability (NCBI, 2022). Because these targets are ubiquitous across various microbial species, the associated drugs often exhibit a wide range of efficacy against bacteria, viruses, and fungi. However, the non-selective nature of these interactions means they can also affect host macromolecules, which generally restricts their clinical application to topical use or environmental sterilization to avoid systemic toxicity. Chlorhexidine specifically targets the negatively charged bacterial cell wall and membrane, causing leakage of intracellular components (PubMed, 2019). This broad targeting strategy is effective for rapid decontamination but lacks the specificity required for systemic therapeutic applications.
Protein denaturation, membrane disruption, oxidation of cellular components, and cross-linking of macromolecules (StatPearls, 2023; CDC, 2008).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial proteins and membrane macromolecules.